AKLI(Delisted)
Akili·NASDAQ
--
--(--)
AKLI Profile
Akili, Inc.
A company that developing therapeutic designed to target cognitive impairment at its source in brain diseases
71 Commercial Street, Mailbox 312, Boston, MA 02109
--
Akili, Inc., was incorporated on December 1, 2011 under the laws of the State of Delaware. The company is a leading digital medicine company, pioneering the development of cognitive therapy through game-changing technology. The company's approach to developing and commercializing technology aimed directly at brain physiology establishes a new class of medicine — drugs that can be validated by clinical trials like drugs or medical devices, but experienced like entertainment.
